Shares of Cardiovascular Systems Inc. (NASDAQ:CSII) shot up 2.1% during trading on Friday . The stock traded as high as $19.32 and last traded at $19.29, with a volume of 309,342 shares trading hands. The stock had previously closed at $18.90.

A number of research firms have commented on CSII. Zacks Investment Research lowered Cardiovascular Systems from a “buy” rating to a “hold” rating in a research note on Tuesday, July 5th. Needham & Company LLC reissued a “buy” rating and issued a $23.00 price objective (up previously from $20.00) on shares of Cardiovascular Systems in a research note on Wednesday, June 29th. Finally, Leerink Swann reissued a “market perform” rating and issued a $15.00 price objective (up previously from $13.00) on shares of Cardiovascular Systems in a research note on Saturday, May 7th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average target price of $20.57.

The stock’s 50-day moving average is $17.97 and its 200 day moving average is $13.40. The stock’s market cap is $632.22 million.

Cardiovascular Systems (NASDAQ:CSII) last released its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($0.31) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.54) by $0.23. The firm had revenue of $44.50 million for the quarter, compared to analyst estimates of $42.13 million. During the same period in the previous year, the business posted ($0.34) earnings per share. The business’s revenue for the quarter was down 5.3% on a year-over-year basis. On average, equities research analysts forecast that Cardiovascular Systems Inc. will post ($1.75) EPS for the current fiscal year.

A hedge fund recently raised its stake in Cardiovascular Systems stock. Brown Advisory Inc. increased its position in Cardiovascular Systems Inc. (NASDAQ:CSII) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 342,446 shares of the medical device company’s stock after buying an additional 7,010 shares during the period. Brown Advisory Inc. owned 1.05% of Cardiovascular Systems worth $5,178,000 at the end of the most recent quarter.

Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary arterial diseases. It has developed an orbital atherectomy technology for peripheral and coronary commercial applications. Its peripheral arterial disease systems are catheter-based platforms that treat plaque types in leg arteries both above and below the knee.